| Active ingredients | Status | Update | Specialty |
| opium (powder), paracetamol] | Supply tension | 16/01/2026 | Izalgi 500 mg/25 mg, capsule |
| bendamustine (hydrochloride) monohydrate] | Supply tension | 16/01/2026 | Bendamustine Hikma 2.5 mg/mL, powder for solution for infusion |
| ascorbic acid] | Return to availability | 16/01/2026 | Laroscorbine 1 g/5 mL, IV injectable solution in ampoule |
| iomeprol] | Supply tension | 15/01/2026 | Ioméron 250, 350, and 400 mg iodine/mL, injectable solution in 50, 100, 200, and 500 mL – |
| Return to availability | 15/01/2026 | Boostrix Tetra, suspension for injection in a pre-filled syringe. Diphtheria, tetanus, pertussis (acellular multicomponent) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen content) | |
| Supply tension | 15/01/2026 | Repevax, suspension for injection in a pre-filled syringe. Diphtheria, tetanus, pertussis (acellular, multi-component) and poliomyelitis (inactivated) vaccine, (adsorbed, reduced antigen content). | |
| ifosfamide] | Stock shortage | 15/01/2026 | Holoxan 1000 mg, powder for solution for injection, and 2000 mg, powder for parenteral use |
| methylphenidate (hydrochloride)] | Supply tension | 14/01/2026 | Methylphenidate EG LP, extended-release tablet |
| olipudase alfa] | Supply tension | 14/01/2026 | Xenpozyme 20 mg, powder for solution for infusion |
| aztreonam] | Stock shortage | 12/01/2026 | Azactam 1 g, powder and solution for parenteral use |
2026年1月19日